Variant report

Variant	esv2760509
Chromosome Location	chr19:41325004-41394336
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1156)
CpG islands
(count:733)
Chromatin interactive
region (count:14)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1156 , 50 per page) page: 1 2 3 4 5 6 7 ... 24

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:41329339-41329381	HepG2	liver:	n/a	n/a
2	ARID3A	chr19:41328860-41329133	K562	blood:	n/a	n/a
3	ARID3A	chr19:41378197-41378436	K562	blood:	n/a	n/a
4	ARID3A	chr19:41325732-41325933	K562	blood:	n/a	n/a
5	ARID3A	chr19:41332662-41332725	K562	blood:	n/a	n/a
6	ARID3A	chr19:41337675-41338160	HepG2	liver:	n/a	n/a
7	ARID3A	chr19:41370633-41370945	K562	blood:	n/a	n/a
8	ARID3A	chr19:41329750-41329937	HepG2	liver:	n/a	n/a
9	ATF1	chr19:41328759-41329240	K562	blood:	n/a	n/a
10	ATF1	chr19:41331479-41331663	K562	blood:	n/a	n/a
11	ATF1	chr19:41339642-41339915	K562	blood:	n/a	n/a
12	ATF1	chr19:41370536-41370948	K562	blood:	n/a	n/a
13	ATF1	chr19:41378237-41378485	K562	blood:	n/a	n/a
14	ATF2	chr19:41328765-41329159	GM12878	blood:	n/a	n/a
15	ATF3	chr19:41337642-41338304	A549	lung:	n/a	n/a
16	ATF3	chr19:41339265-41339474	K562	blood:	n/a	n/a
17	ATF3	chr19:41378141-41378430	K562	blood:	n/a	n/a
18	ATF3	chr19:41370620-41370877	K562	blood:	n/a	n/a
19	ATF3	chr19:41328783-41329158	K562	blood:	n/a	n/a
20	ATF3	chr19:41339727-41339986	K562	blood:	n/a	n/a
21	BATF	chr19:41328854-41329148	GM12878	blood:	n/a	n/a
22	BATF	chr19:41328872-41329097	GM12878	blood:	n/a	n/a
23	BCL3	chr19:41337399-41338400	A549	lung:	n/a	n/a
24	BCL3	chr19:41337271-41338291	A549	lung:	n/a	n/a
25	BCL3	chr19:41325415-41325988	A549	lung:	n/a	n/a
26	BCL3	chr19:41324316-41325122	A549	lung:	n/a	n/a
27	BHLHE40	chr19:41337763-41338048	HepG2	liver:	n/a	chr19:41337896-41337917
28	BHLHE40	chr19:41337704-41338087	A549	lung:	n/a	chr19:41337896-41337917
29	BHLHE40	chr19:41337685-41338115	K562	blood:	n/a	chr19:41337896-41337917
30	BHLHE40	chr19:41325720-41325781	GM12878	blood:	n/a	n/a
31	BHLHE40	chr19:41339813-41339844	K562	blood:	n/a	n/a
32	BHLHE40	chr19:41328602-41329132	K562	blood:	n/a	n/a
33	BHLHE40	chr19:41339267-41339464	K562	blood:	n/a	n/a
34	BHLHE40	chr19:41337782-41338177	HepG2	liver:	n/a	chr19:41337896-41337917
35	BHLHE40	chr19:41328117-41328352	K562	blood:	n/a	n/a
36	BHLHE40	chr19:41332617-41332833	K562	blood:	n/a	n/a
37	BHLHE40	chr19:41337595-41338254	HepG2	liver:	n/a	chr19:41337896-41337917
38	BRCA1	chr19:41325734-41325927	Hela-S3	cervix:	n/a	n/a
39	BRCA1	chr19:41337806-41338121	Hela-S3	cervix:	n/a	n/a
40	BRCA1	chr19:41329863-41330001	HepG2	liver:	n/a	n/a
41	CBX3	chr19:41349182-41350047	K562	blood:	n/a	n/a
42	CBX3	chr19:41379769-41380227	K562	blood:	n/a	n/a
43	CBX3	chr19:41379821-41380148	K562	blood:	n/a	n/a
44	CBX3	chr19:41339143-41339980	K562	blood:	n/a	n/a
45	CBX3	chr19:41370123-41371107	K562	blood:	n/a	n/a
46	CBX3	chr19:41381255-41381833	K562	blood:	n/a	n/a
47	CBX3	chr19:41347915-41348277	K562	blood:	n/a	n/a
48	CBX3	chr19:41337733-41338384	K562	blood:	n/a	n/a
49	CBX3	chr19:41332491-41333023	K562	blood:	n/a	n/a
50	CBX3	chr19:41347938-41348304	K562	blood:	n/a	n/a

(count:733 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:41355973-41356023	AG04449	skin:	fetal
2	chr19:41355973-41356023	AG04449	skin:	fetal
3	chr19:41385865-41385915	HCT-116	colon:	n/a
4	chr19:41389684-41389734	SK-N-SH	brain:	n/a
5	chr19:41386441-41386491	SK-N-MC	brain:	n/a
6	chr19:41383654-41383704	PrEC	prostate:	n/a
7	chr19:41386441-41386491	HEEpiC	esophagus:	n/a
8	chr19:41388384-41388434	HEK293	kidney:	embryo
9	chr19:41351924-41351974	AoSMC	blood vessel:	n/a
10	chr19:41355973-41356023	NH-A	brain:	n/a
11	chr19:41388232-41388282	HPAEpiC	pulmonary alveolar:	n/a
12	chr19:41388232-41388282	HepG2	liver:	n/a
13	chr19:41389684-41389734	HRE	kidney:	n/a
14	chr19:41354553-41354603	GM12892	blood:	n/a
15	chr19:41386441-41386491	AG09319	gingival:	n/a
16	chr19:41354682-41354732	GM19239	blood:	n/a
17	chr19:41386441-41386491	Jurkat	blood:	n/a
18	chr19:41355973-41356023	NB4	blood:	n/a
19	chr19:41386507-41386557	MCF10A-Er-Src	breast:	n/a
20	chr19:41351924-41351974	SKMC	muscle:	n/a
21	chr19:41354553-41354603	AoSMC	blood vessel:	n/a
22	chr19:41354142-41354192	CMK	blood:	n/a
23	chr19:41383654-41383704	Caco-2	colon:	n/a
24	chr19:41388232-41388282	HNPCEpiC	eye:	n/a
25	chr19:41388384-41388434	HMEC	breast:	n/a
26	chr19:41385865-41385915	GM12891	blood:	n/a
27	chr19:41385865-41385915	NH-A	brain:	n/a
28	chr19:41354142-41354192	SAEC	small airway:	n/a
29	chr19:41355973-41356023	HMEC	breast:	n/a
30	chr19:41388232-41388282	PFSK-1	brain:	n/a
31	chr19:41386441-41386491	HEK293	kidney:	embryo
32	chr19:41385865-41385915	HRE	kidney:	n/a
33	chr19:41351924-41351974	AG09309	skin:	n/a
34	chr19:41383654-41383704	CMK	blood:	n/a
35	chr19:41354142-41354192	U87	brain:	n/a
36	chr19:41388232-41388282	HEK293	kidney:	embryo
37	chr19:41388384-41388434	PFSK-1	brain:	n/a
38	chr19:41389684-41389734	AG09309	skin:	n/a
39	chr19:41385865-41385915	HIPEpiC	eye:	n/a
40	chr19:41354682-41354732	HEEpiC	esophagus:	n/a
41	chr19:41389684-41389734	AG09319	gingival:	n/a
42	chr19:41386507-41386557	HPAEpiC	pulmonary alveolar:	n/a
43	chr19:41386441-41386491	NT2-D1	testis:	n/a
44	chr19:41355973-41356023	ProgFib	skin:	n/a
45	chr19:41389684-41389734	HRCEpiC	kidney:	n/a
46	chr19:41383654-41383704	H1-hESC	embryonic stem cell:	embryo
47	chr19:41386441-41386491	HepG2	liver:	n/a
48	chr19:41388232-41388282	SKMC	muscle:	n/a
49	chr19:41351924-41351974	A549	lung:	n/a
50	chr19:41386507-41386557	HepG2	liver:	n/a

(count:14 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:41168873..41171001-chr19:41337568..41339858,2	MCF-7	breast:
2	chr19:41308981..41310761-chr19:41328950..41331084,2	K562	blood:
3	chr19:41195484..41197379-chr19:41368669..41371255,2	K562	blood:
4	chr16:4474827..4477394-chr19:41351022..41353007,2	MCF-7	breast:
5	chr19:41305847..41307435-chr19:41322147..41325035,2	K562	blood:
6	chr19:41252878..41254657-chr19:41324128..41326565,2	K562	blood:
7	chr19:41309668..41312632-chr19:41335922..41337729,2	MCF-7	breast:
8	chr19:41369230..41371017-chr19:41372027..41374078,2	K562	blood:
9	chr19:41323756..41325875-chr19:41632979..41635488,2	MCF-7	breast:
10	chr19:41369230..41371017-chr19:41372027..41374078,2	K562	blood:
11	chr19:41333069..41334753-chr19:41334934..41336779,2	K562	blood:
12	chr19:41333069..41334753-chr19:41334934..41336779,2	K562	blood:
13	chr19:41167522..41169643-chr19:41327340..41330313,2	K562	blood:
14	chr19:41256025..41258219-chr19:41326526..41328364,2	K562	blood:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CYP2A6-1	chr19:41342991-41343115	ENSG00000269843.1
2	lnc-CYP2A6-1	chr19:41337126-41337482	ENSG00000269843.1

No data

Variant related genes	Relation type
ENSG00000269843	TF binding region
CYP2G1P	TF binding region
CYP2F2P	TF binding region
CYP2A6	TF binding region
CYP2A7	TF binding region
ENSG00000269843	CpG island
CYP2G1P	CpG island
CYP2F2P	CpG island
CYP2A6	CpG island
CYP2A7	CpG island
ENSG00000103423	chromatin interactions
ENSG00000105245	chromatin interactions
ENSG00000262246	chromatin interactions
ENSG00000269858	chromatin interactions
ENSG00000268797	chromatin interactions
ENSG00000188493	chromatin interactions
ENSG00000077312	chromatin interactions

Extended variants
information (count: 3567 )
Associated
traits (count: 65 )

Variant overlapped rSNPs/rCNVs (count:3567 , 50 per page) page: 1 2 3 4 5 6 7 ... 72

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs114078318	chr19:41325007-41325008	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs141084373	chr19:41325032-41325033	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs539633894	chr19:41325036-41325037	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs113505230	chr19:41325043-41325044	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs112518112	chr19:41325050-41325051	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs115947763	chr19:41325060-41325061	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs112711471	chr19:41325073-41325074	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs180672633	chr19:41325080-41325081	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs111827135	chr19:41325081-41325082	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs554312419	chr19:41325113-41325114	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs185938953	chr19:41325119-41325120	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs573282689	chr19:41325129-41325130	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs537785857	chr19:41325197-41325198	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs146465456	chr19:41325199-41325200	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs577816507	chr19:41325200-41325201	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs544877703	chr19:41325213-41325214	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs560251202	chr19:41325239-41325240	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs558197495	chr19:41325259-41325260	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs181874503	chr19:41325273-41325274	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs540700254	chr19:41325328-41325329	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs562093186	chr19:41325406-41325407	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs186199160	chr19:41325407-41325408	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs190505753	chr19:41325423-41325424	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs563036529	chr19:41325543-41325544	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs367589269	chr19:41325554-41325555	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs577046437	chr19:41325593-41325594	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs533636587	chr19:41325602-41325603	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs551699225	chr19:41325624-41325625	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs183048052	chr19:41325630-41325631	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs567027373	chr19:41325644-41325645	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs186314619	chr19:41325767-41325768	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs533670766	chr19:41325789-41325790	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs548655103	chr19:41325799-41325800	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs566966406	chr19:41325820-41325821	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs537446353	chr19:41325826-41325827	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs563299636	chr19:41325867-41325868	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs571458400	chr19:41325973-41325974	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs538889036	chr19:41326055-41326056	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs191172314	chr19:41326081-41326082	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs368180549	chr19:41326213-41326214	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs553703640	chr19:41326323-41326324	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs532356941	chr19:41326331-41326332	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs183020639	chr19:41326332-41326333	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs540764948	chr19:41326344-41326345	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs544433334	chr19:41326372-41326373	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs186614197	chr19:41326376-41326377	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs574128097	chr19:41326406-41326407	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs4803373	chr19:41326426-41326427	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	mRNA abundance
49	rs201492898	chr19:41326431-41326432	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs562868380	chr19:41326435-41326436	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:65)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Lung adenocarcinoma	21935476	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:1082 , 50 per page) page: 1 2 3 4 5 6 7 ... 22

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:41315000-41332600	Weak transcription	Aorta	Aorta
2	chr19:41316400-41325400	Weak transcription	Dnd41	blood
3	chr19:41320200-41332800	Weak transcription	HSMMtube	muscle
4	chr19:41322600-41330600	Enhancers	Placenta	Placenta
5	chr19:41322800-41326000	Enhancers	Primary T helper cells PMA-I stimulated	--
6	chr19:41323200-41326200	Enhancers	Primary T killer naive cells fromperipheralblood	blood
7	chr19:41323800-41325400	Enhancers	Fetal Intestine Small	intestine
8	chr19:41323800-41325800	Enhancers	Primary T killer memory cells from peripheral blood	blood
9	chr19:41323800-41325800	Enhancers	Liver	Liver
10	chr19:41323800-41325800	Enhancers	Colon Smooth Muscle	Colon
11	chr19:41323800-41325800	Enhancers	Fetal Stomach	stomach
12	chr19:41324000-41325800	Enhancers	Primary hematopoietic stem cells short term culture	blood
13	chr19:41324000-41326000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
14	chr19:41324000-41326000	Enhancers	Fetal Thymus	thymus
15	chr19:41324200-41325200	Enhancers	Stomach Mucosa	stomach
16	chr19:41324200-41325800	Enhancers	Breast Myoepithelial Primary Cells	Breast
17	chr19:41324200-41325800	Enhancers	GM12878-XiMat	blood
18	chr19:41324400-41325200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
19	chr19:41324400-41325800	Enhancers	Spleen	Spleen
20	chr19:41324400-41325800	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
21	chr19:41324400-41326000	Enhancers	Primary hematopoietic stem cells	blood
22	chr19:41324400-41327200	Enhancers	K562	blood
23	chr19:41324600-41325200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
24	chr19:41324600-41325400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
25	chr19:41324600-41325400	Enhancers	Fetal Muscle Trunk	muscle
26	chr19:41324600-41325600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
27	chr19:41324600-41325800	Enhancers	HUVEC	blood vessel
28	chr19:41324600-41326000	Enhancers	Primary B cells from cord blood	blood
29	chr19:41324600-41328200	Weak transcription	Gastric	stomach
30	chr19:41324600-41328200	Weak transcription	Left Ventricle	heart
31	chr19:41324600-41328200	Weak transcription	Lung	lung
32	chr19:41324600-41328400	Weak transcription	Fetal Lung	lung
33	chr19:41324600-41328600	Weak transcription	NH-A	brain
34	chr19:41324600-41332600	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
35	chr19:41324600-41332600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
36	chr19:41324600-41332600	Weak transcription	Pancreatic Islets	Pancreatic Islet
37	chr19:41324600-41332600	Weak transcription	NHLF	lung
38	chr19:41324800-41325200	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
39	chr19:41324800-41325200	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
40	chr19:41324800-41325200	Enhancers	Brain Inferior Temporal Lobe	brain
41	chr19:41324800-41325200	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
42	chr19:41324800-41325200	Weak transcription	Brain Substantia Nigra	brain
43	chr19:41324800-41325200	Weak transcription	Fetal Intestine Large	intestine
44	chr19:41324800-41325200	Enhancers	NHDF-Ad	bronchial
45	chr19:41324800-41325200	Enhancers	Osteobl	bone
46	chr19:41324800-41325400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
47	chr19:41324800-41325400	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
48	chr19:41324800-41325600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
49	chr19:41324800-41325800	Enhancers	HUES6 Cell Line	embryonic stem cell
50	chr19:41324800-41325800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links